Why Lysodren®

Learn why Lysodren® is prescribed to treat ACC and how it works

How Does It Work?

Lysodren® is used when surgery cannot remove the tumor.1

Lysodren® has 2 main actions 2:

1

It ACTS against tumors

destroying cancer cells

2

It controls hormones

improving symptoms caused by the excess hormones

In other words, Lysodren® helps to stop tumors from growing while reducing hormone levels, in certain patients.*

Lysodren® needs time to build up in your body before it starts working effectively. Even if your dose is not changed for a while, the level in your blood can continue to rise over time. If it gets too high, you may be asked to stop taking it for a few days and restart at a lower dose.3

*The precise way Lysodren® works is not completely understood.

When Is It Prescribed?4

Lysodren® Results (efficacy outcomes)

In a clinical study of 127 patients diagnosed with ACC5:

stat
Overall survival (OS) averaged 18.5 months (1.3 to 220 months) after starting Lysodren®
stat
In total, 50 patients (40.9%) experienced clinical benefit (disease control greater than 180 days)
stat
28 patients (22.0%) experienced a long-term benefit of greater than 12 months
  1. Chemotherapy for Adrenal Cancer. American Cancer Society. January 2, 2018. Accessed April 2, 2024. https://www.cancer.org/cancer/types/adrenal-cancer/treating/chemotherapy.html
  2. Waszut U, Szyszka P, Dworakowska D. Understanding mitotane mode of action. J Physiol Pharmacol. 2017;68(1):13-26.
  3. Lysodren®. US Prescribing information. ESTEVE.
  4. Mitotane (Lysodren). Cancer Research UK. Accessed April 9, 2024. https://www.cancerresearchuk.org/about-cancer/treatment/drugs/mitotane-lysodren
  5. Megerle F, Herrmann W, Schloetelburg W, et al. Mitotane monotherapy in patients with advanced adrenocortical carcinoma. J Clin Endocrinol Metab. 2018;103(4):1686-1695. doi:10.1210/jc.2017-02591
ESTEVE.
Passeig de la Zona Franca, 109, 4a planta, 08038 Barcelona
Tel: +34 93 446 60 00 / Fax: +34 93 347 39 44
©2025 ESTEVE.
Lysodren a registered trademark of ESTEVE
Privacy Notice | Cookie Statement
Last updated: October 2025; 0097-10/2026@ESTEVE

You are now leaving Lysodren

Lysodren provides links to web sites of other organizations in order to provide visitors with certain information. A link does not constitute an endorsement of content, viewpoint, policies, products or services of that web site. Once you link to another web site not maintained by Lysodren, you are subject to the terms and conditions of that web site, including but not limited to its privacy policy.

You will be redirected to

Click the link above to continue or CANCEL